Starting from scratch on neovascular age-related macular degeneration
AMD treatment may become unrecognisable as gene therapies evolve
Clinicians keep their eyes on wartime ocular trauma
Every day brings a new challenge for surgeons in low-resource areas and conflict zones
Recap: The future of imaging is out of this world
Highlights from the 2025 Heidelberg Engineering International SPECTRALIS Symposium—And Beyond
Eyeing the brain: How ocular mitochondrial disease may predict dementia risk
Consistent trends across prevalence, incidence, odds and time-to-event models suggest ocular mitochondrial disease may indicate neurodegenerative risk
A realistic view of diabetes remission: GLP-1 therapies and the future of diabetic retinopathy
GLP-1 therapies could impact long-term outcomes in diabetic retinopathy
Feasibility of artificial intelligence in leading glaucoma care
Can AI compete with the well-oiled machine of the contemporary clinic?
Managing and monitoring the global burden of retinoblastoma
Enhanced screenings and a unified registry could save vision and lives
